London’s equity markets closed higher on Friday, with the FTSE 100 advancing modestly as gains in healthcare and beverages stocks offset broader caution ahead of the closely watched US non-farm payrolls report. The session reflected a market in a careful holding pattern, where sector-specific momentum provided direction while macro uncertainty kept appetite measured. According to London Hub Global analysts, the day’s trading illustrated how London’s benchmark index continues to draw support from its defensive composition even when global sentiment remains fragile.
The FTSE 100 rose approximately 0.3%, with AstraZeneca and Diageo among the notable contributors to the day’s gains. AstraZeneca, one of the index’s largest constituents by market capitalisation, extended its recent recovery on the back of continued investor confidence in its oncology pipeline and global drug delivery partnerships. Diageo, the beverages giant behind brands including Johnnie Walker and Guinness, also moved higher, benefiting from expectations of stabilising consumer demand in key international markets after a period of softer volumes.
The outperformance of healthcare and consumer staples within the UK financial markets reflects a broader rotation that has been building across European equities. Investors have been trimming exposure to rate-sensitive growth stocks and reallocating toward sectors with more predictable earnings profiles. The FTSE 100, which carries a structurally heavier weighting in energy, mining, pharmaceuticals and consumer goods compared to US indices, has benefited from this dynamic throughout much of 2024 and into 2025.
The Bank of England’s monetary policy trajectory remains a central variable for UK financial markets. With UK inflation showing gradual progress toward the 2% target, markets have been pricing in a cautious easing cycle, though the pace of rate cuts has remained slower than many had anticipated at the start of the year. UK interest rates currently sit at levels that continue to compress valuations in growth-oriented segments of the London stock market, making dividend-rich defensive names comparatively more attractive to institutional allocators.
The US jobs data released later in the session carried particular weight for global risk sentiment. Non-farm payrolls figures serve as a primary input for Federal Reserve rate expectations, and any significant deviation from consensus forecasts tends to ripple through currency markets, bond yields and equity indices worldwide. A stronger-than-expected reading would likely reinforce the Fed’s cautious stance on rate cuts, strengthening the dollar and applying pressure on sterling-denominated assets. A softer reading could revive expectations of earlier Fed easing, which historically supports risk appetite across UK and European markets.
For the City of London, the dollar-sterling exchange rate carries direct implications beyond equity pricing. A sustained period of dollar strength compresses the sterling value of overseas earnings repatriated by FTSE 100 multinationals, many of which generate the majority of their revenues outside the United Kingdom. At the same time, a weaker pound can inflate import costs, feeding back into UK inflation and complicating the Bank of England’s path toward rate normalisation. We at London Hub Global emphasize that this feedback loop between US monetary signals and London business conditions is one of the more underappreciated transmission mechanisms in the current cycle.
London’s investment climate more broadly has been navigating a complex set of pressures. The UK government’s fiscal adjustments, including changes to employer National Insurance contributions introduced in the autumn budget, have added to cost pressures for businesses operating in the capital. Corporate hiring intentions in London have softened in recent surveys, and commercial property demand in key City districts has remained uneven. Against this backdrop, the resilience of large-cap equities on the London stock market provides a degree of reassurance, though it does not fully reflect conditions across the wider London economy.
The FTSE 100’s performance on the day also drew context from recent earnings updates across the healthcare sector. Pharmaceutical companies listed in London have been reporting solid revenue growth driven by demand for weight-loss treatments, oncology therapies and biosimilars, areas where UK-listed firms hold competitive positions. This has reinforced the index’s appeal to international investors seeking exposure to global healthcare trends through a market that offers relative valuation discipline compared to US peers.
London Hub Global analysts forecast that the near-term direction of the FTSE 100 will remain sensitive to three converging factors: the pace of Bank of England rate cuts, the trajectory of the US economy as reflected in labour market data, and the earnings resilience of the index’s largest sector constituents. Should US payrolls data point to a cooling labour market, the resulting shift in Fed expectations could provide a tailwind for UK equities by easing pressure on global borrowing costs and supporting risk appetite. Conversely, persistent labour market strength in the United States would likely extend the current environment of elevated rates, keeping the defensive tilt of the FTSE 100 as the path of least resistance for investors. In our view at London Hub Global, the index’s structural composition positions it reasonably well for a prolonged period of macro uncertainty, though the broader London economy will require more than equity market stability to sustain its recovery momentum through the remainder of the year.
